Trials / Completed
CompletedNCT02580903
Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms
Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis. All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association. All patients will be followed up for a total of five years to identify prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiology | Only a small subsample will require CT and right heart catherisation |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2018-02-01
- Completion
- 2020-02-01
- First posted
- 2015-10-20
- Last updated
- 2020-09-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02580903. Inclusion in this directory is not an endorsement.